BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alves M, Caldeira D, Ferro JM, Ferreira JJ. Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta-analysis. Eur J Neurol 2020;27:288-96. [PMID: 31454134 DOI: 10.1111/ene.14076] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Li F, Wang Y, Hou X, Cao L, Zhou X, Yuan W, Shen Y, Tian T. Genetic predisposition to neurodegenerative diseases and risk of stroke: A Mendelian randomization study. Front Neurosci 2022;16. [DOI: 10.3389/fnins.2022.995045] [Reference Citation Analysis]
2 Chua SKK, Saffari SE, Lee SJY, Tan E. Association Between Parkinson’s Disease and Coronary Artery Disease: A Systematic Review and Meta-Analysis. JPD 2022;12:1737-1748. [DOI: 10.3233/jpd-223291] [Reference Citation Analysis]
3 Macías-García D, Periñán MT, Muñoz-Delgado L, Jesús S, Jimenez-Jaraba MV, Buiza-Rueda D, Bonilla-Toribio M, Adarmes-Gómez A, Carrillo F, Gómez-Garre P, Mir P. Reply to: "Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations". Mov Disord 2022;37:1119-20. [PMID: 35587631 DOI: 10.1002/mds.28995] [Reference Citation Analysis]
4 Huang C, Lai Y, Lien C, Cheng B, Kung C, Chiang Y, Lu C. Effectiveness of Different Methods for Baroreflex Sensitivity Assessment in Determining the Severity of Cardiovascular Autonomic Neuropathy in Patients With Parkinson’s Disease. Front Neurosci 2022;16:833344. [DOI: 10.3389/fnins.2022.833344] [Reference Citation Analysis]
5 Fang S, Hu X, Wang T, Yang Y, Xu R, Zhang X, Luo J, Ma Y, Patel AB, Dmytriw AA, Jiao L. Parkinson's Disease and Ischemic Stroke: a Bidirectional Mendelian Randomization Study. Transl Stroke Res 2022. [PMID: 35013977 DOI: 10.1007/s12975-021-00974-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Scorza FA, Guimarães-marques M, Nejm M, de Almeida ACG, Scorza CA, Fiorini AC, Finsterer J. Sudden unexpected death in Parkinson's disease: Insights from clinical practice. Clinics 2022;77:100001. [DOI: 10.1016/j.clinsp.2021.100001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Alves M, Pita Lobo P, Azevedo Kauppila L, Rebordão L, Cruz MM, Guerreiro C, Ferro JM, Ferreira JJ, Reimão S. Neuroimaging cerebrovascular biomarkers in Parkinson's disease. Neuroradiol J 2021;:19714009211059118. [PMID: 34872414 DOI: 10.1177/19714009211059118] [Reference Citation Analysis]
8 Macías-García D, Periñán MT, Muñoz-Delgado L, Jesús S, Jimenez-Jaraba MV, Buiza-Rueda D, Bonilla-Toribio M, Adarmes-Gómez A, Carrillo F, Gómez-Garre P, Mir P. Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations. Mov Disord 2021. [PMID: 34859503 DOI: 10.1002/mds.28863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wang M, Zhang Z, Liu D, Ji L, Huang S, Cao L, Wei N, Ye D, Ma Y, Lian X. Genetic predisposition to Parkinson's disease and risk of cardio and cerebrovascular disease: a Mendelian randomization study. Parkinsonism Relat Disord 2021;94:49-53. [PMID: 34883359 DOI: 10.1016/j.parkreldis.2021.11.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Orayj K. Impact of Antidepressants on Cardiac Events and All-Cause Mortality in Parkinson's Disease: A National Data-Linkage Study. Neuropsychiatr Dis Treat 2021;17:2499-510. [PMID: 34354357 DOI: 10.2147/NDT.S325521] [Reference Citation Analysis]
11 Orayj K. Cardiovascular Events Associated with Antipsychotics in Newly Diagnosed Parkinson's Disease Patients: A Propensity Score Matched Cohort Study. Int J Gen Med 2021;14:2975-87. [PMID: 34234527 DOI: 10.2147/IJGM.S319600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yoon SY, Shin J, Kim YW, Chang JS, Won Kim H. The mortality rate of Parkinson's disease and related comorbidities: a nationwide population-based matched cohort study in Korea. Age Ageing 2021;50:1182-8. [PMID: 33219665 DOI: 10.1093/ageing/afaa250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Alves M, Pita Lobo P, Kauppila LA, Rebordão L, Cruz MM, Soares F, Cruz J, Tornada A, Caldeira D, Reimão S, Oliveira V, Ferro JM, Ferreira JJ. Cardiovascular and cerebrovascular risk markers in Parkinson's disease: Results from a case-control study. Eur J Neurol 2021;28:2669-79. [PMID: 34033182 DOI: 10.1111/ene.14938] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Alves M, Abrantes AM, Portugal G, Cruz MM, Reimão S, Caldeira D, Ferro JM, Ferreira JJ. Does Parkinson's Disease Increase the Risk of Atrial Fibrillation? Insights From Electrocardiogram and Risk Scores From a Case-Control Study. Front Neurol 2021;12:633900. [PMID: 34054687 DOI: 10.3389/fneur.2021.633900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Han S, Moon I, Choi EK, Han KD, Cho HC, Lee SY, Yang S, Kwon S, Choi YJ, Lee HJ, Lee E, Lee SR, Oh S. Increased atrial fibrillation risk in Parkinson's disease: A nationwide population-based study. Ann Clin Transl Neurol 2021;8:238-46. [PMID: 33389803 DOI: 10.1002/acn3.51279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Abugroun A, Taha A, Abdel-Rahman M, Patel P, Ali I, Klein LW. Cardiovascular Risk Among Patients ≥65 Years of Age with Parkinson's Disease (From the National Inpatient Sample). Am J Cardiol 2020;136:56-61. [PMID: 32941821 DOI: 10.1016/j.amjcard.2020.09.021] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Nejm M, Guimarães-marques M, Scorza CA, Victorino DB, Finsterer J, Fiorini AC, Scorza FA. Air pollution and sudden death risk in patients with Parkinson’s disease: Assessing the evidence to date. Public Health in Practice 2020;1:100008. [DOI: 10.1016/j.puhip.2020.100008] [Reference Citation Analysis]
18 Victorino DB, Nejm MB, Guimarães-Marques MJ, Scorza CA, Fiorini AC, Finsterer J, Scorza FA. Domperidone in Parkinson's disease: a valuable controversy, but unnecessary panic. Fam Pract 2020;37:723-4. [PMID: 32473008 DOI: 10.1093/fampra/cmaa054] [Reference Citation Analysis]
19 Alves M, Caldeira D, Ferro JM, Ferreira JJ. Reply to the letter ‘We never speak about sudden unexpected death in Parkinson’s disease’. Eur J Neurol 2020;27. [DOI: 10.1111/ene.14216] [Reference Citation Analysis]
20 Rodrigues LD, Oliveira LF, Scorza CA, Andersen ML, Tufik S, Finsterer J, Scorza FA. We never speak about sudden unexpected death in Parkinson's disease. Eur J Neurol 2020;27:e30. [PMID: 32170982 DOI: 10.1111/ene.14217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Alves M, Caldeira D, Rato ML, Duarte GS, Ferreira AN, Ferro J, Ferreira JJ. Cardiovascular Adverse Events Reported in Placebo Arm of Randomized Controlled Trials in Parkinson’s Disease. JPD 2020;10:641-51. [DOI: 10.3233/jpd-191907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Alves M, Caldeira D, Ferro JM, Ferreira JJ. Reply to letter: Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta-analysis. Eur J Neurol 2020;27:e12. [PMID: 31710751 DOI: 10.1111/ene.14125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]